122 related articles for article (PubMed ID: 11936766)
21. Protein A as a molecular probe for the detection of antigen induced conformational change in Fc region of rabbit antibody.
Moţa G; Moraru I; Sjöquist J; Gheţie V
Mol Immunol; 1981 May; 18(5):373-8. PubMed ID: 7311974
[No Abstract] [Full Text] [Related]
22. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
23. Single amino acid substitution in the mouse IgG1 Fc region induces drastic enhancement of the affinity to protein A.
Nagaoka M; Akaike T
Protein Eng; 2003 Apr; 16(4):243-5. PubMed ID: 12736366
[TBL] [Abstract][Full Text] [Related]
24. Purification of an Fc-fusion biologic: clearance of multiple product related impurities by hydrophobic interaction chromatography.
Evans DR; Macniven RP; Labanca M; Walker J; Notarnicola SM
J Chromatogr A; 2008 Jan; 1177(2):265-71. PubMed ID: 17692855
[TBL] [Abstract][Full Text] [Related]
25. Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties.
Soleimanpour S; Hassannia T; Motiee M; Amini AA; Rezaee SA
Crit Rev Biotechnol; 2017 May; 37(3):371-392. PubMed ID: 27049690
[TBL] [Abstract][Full Text] [Related]
26. Immunoassay of serum alpha(1)-antitrypsin by affinity-probe capillary isoelectric focusing using a fluorescence-labeled recombinant antibody fragment.
Shimura K; Hoshino M; Kamiya K; Katoh K; Hisada S; Matsumoto H; Kasai K
Electrophoresis; 2002 Mar; 23(6):909-17. PubMed ID: 11920876
[TBL] [Abstract][Full Text] [Related]
27. Protein A-like activity and streptococcal cross-reactions.
Kingston D
Clin Exp Immunol; 1981 Oct; 46(1):225-8. PubMed ID: 7039880
[TBL] [Abstract][Full Text] [Related]
28. Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach.
Linhult M; Gülich S; Gräslund T; Simon A; Karlsson M; Sjöberg A; Nord K; Hober S
Proteins; 2004 May; 55(2):407-16. PubMed ID: 15048831
[TBL] [Abstract][Full Text] [Related]
29. [Study of the lymphocytic receptor binding immunoglobulin G Fc fragment].
Nowak J
Postepy Hig Med Dosw; 1981; 35(2):129-58. PubMed ID: 7038649
[No Abstract] [Full Text] [Related]
30. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
[TBL] [Abstract][Full Text] [Related]
31. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
Lee TY; Tjin Tham Sjin RM; Movahedi S; Ahmed B; Pravda EA; Lo KM; Gillies SD; Folkman J; Javaherian K
Clin Cancer Res; 2008 Mar; 14(5):1487-93. PubMed ID: 18316573
[TBL] [Abstract][Full Text] [Related]
32. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
[TBL] [Abstract][Full Text] [Related]
33. The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.
van Schravendijk MR; Dwek RA
Mol Immunol; 1981 Dec; 18(12):1079-85. PubMed ID: 6977701
[No Abstract] [Full Text] [Related]
34. [Method of detecting soluble immune complexes using IgG Fc fragments].
Semenov VM; Azarenok KS; Zhavnenko VM
Lab Delo; 1985; (8):467-9. PubMed ID: 2414545
[No Abstract] [Full Text] [Related]
35. Antibody variable region interactions with Protein A: implications for the development of generic purification processes.
Ghose S; Allen M; Hubbard B; Brooks C; Cramer SM
Biotechnol Bioeng; 2005 Dec; 92(6):665-73. PubMed ID: 16206278
[TBL] [Abstract][Full Text] [Related]
36. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
[TBL] [Abstract][Full Text] [Related]
37. Development of XPA067.06, a potent high affinity human anti-gastrin monoclonal antibody.
Hsu SJ; Patel A; Larsen PD; Bohmann DJ; Bauer RJ; Ma JK; Masat L; Roell M; Babuka SJ; Hansen RK; White M; Haak-Frendscho M
Biochem Pharmacol; 2008 Aug; 76(3):340-52. PubMed ID: 18589401
[TBL] [Abstract][Full Text] [Related]
38. Engineered staphylococcal protein A's IgG-binding domain with cathepsin L inhibitory activity.
Bratkovic T; Berlec A; Popovic T; Lunder M; Kreft S; Urleb U; Strukelj B
Biochem Biophys Res Commun; 2006 Oct; 349(1):449-53. PubMed ID: 16935262
[TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
[TBL] [Abstract][Full Text] [Related]
40. Simultaneously targeting nitrocellulose and antibody by a dual-headed protein.
Tran-Nguyen TS; Ngo-Luong DT; Nguyen-Phuoc KH; Tran TL; Tran-Van H
Protein Expr Purif; 2021 Jan; 177():105764. PubMed ID: 32971296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
